dc.contributor.author |
Bello-Chavolla, Omar Yaxmehen |
|
dc.contributor.author |
Antonio-Villa, Neftali Eduardo |
|
dc.contributor.author |
Fermin-Martinez, Carlos A. |
|
dc.contributor.author |
Fernandez-Chirino, Luisa |
|
dc.contributor.author |
Vargas-Vazquez, Arsenio |
|
dc.contributor.author |
Ramirez-Garcia, Daniel |
|
dc.contributor.author |
Basile-Alvarez, Martin Roberto |
|
dc.contributor.author |
Hoyos-Lazaro, Ana Elena |
|
dc.contributor.author |
Carrillo Larco, Rodrigo Martín |
|
dc.contributor.author |
Wexler, Deborah J. |
|
dc.contributor.author |
Manne-Goehler, Jennifer |
|
dc.contributor.author |
Seiglie, Jacqueline A. |
|
dc.date.accessioned |
2022-11-15T23:04:37Z |
|
dc.date.available |
2022-11-15T23:04:37Z |
|
dc.date.issued |
2022 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12866/12529 |
|
dc.description.abstract |
OBJECTIVE: To estimate diabetes-related mortality in Mexico in 2020 compared with 2017-2019 after the onset of the coronavirus disease 2019 (COVID-19) pandemic.RESEARCH DESIGN AND METHODS: This retrospective, state-level study used national death registries of Mexican adults aged ≥20 years for the 2017-2020 period. Diabetes-related death was defined using ICD-10 codes listing diabetes as the primary cause of death, excluding certificates with COVID-19 as the primary cause of death. Spatial and negative binomial regression models were used to characterize the geographic distribution and sociodemographic and epidemiologic correlates of diabetes-related excess mortality, estimated as increases in diabetes-related mortality in 2020 compared with average 2017-2019 rates.RESULTS: We identified 148,437 diabetes-related deaths in 2020 (177 per 100,000 inhabitants) vs. an average of 101,496 deaths in 2017-2019 (125 per 100,000 inhabitants). In-hospital diabetes-related deaths decreased by 17.8% in 2020 versus 2017-2019, whereas out-of-hospital deaths increased by 89.4%. Most deaths were attributable to type 2 diabetes (130 per 100,000 inhabitants). Compared with 2018-2019 data, hyperglycemic hyperosmolar state and diabetic ketoacidosis were the two contributing causes with the highest increase in mortality (128% and 116% increase, respectively). Diabetes-related excess mortality clustered in southern Mexico and was highest in states with higher social lag, rates of COVID-19 hospitalization, and prevalence of HbA1c ≥7.5%.CONCLUSIONS: Diabetes-related deaths increased among Mexican adults by 41.6% in 2020 after the onset of the COVID-19 pandemic, occurred disproportionately outside the hospital, and were largely attributable to type 2 diabetes and hyperglycemic emergencies. Disruptions in diabetes care and strained hospital capacity may have contributed to diabetes-related excess mortality in Mexico during 2020. |
en_US |
dc.language.iso |
eng |
|
dc.publisher |
American Diabetes Association |
|
dc.relation.ispartofseries |
Diabetes Care |
|
dc.rights |
info:eu-repo/semantics/restrictedAccess |
|
dc.rights.uri |
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es |
|
dc.subject |
Diabetes Mortality |
en_US |
dc.subject |
Mexico |
en_US |
dc.subject |
National Death Registries |
en_US |
dc.title |
Diabetes-Related Excess Mortality in Mexico: A Comparative Analysis of National Death Registries Between 2017-2019 and 2020. |
en_US |
dc.type |
info:eu-repo/semantics/article |
|
dc.identifier.doi |
https://doi.org/10.2337/dc22-0616 |
|
dc.subject.ocde |
https://purl.org/pe-repo/ocde/ford#3.02.18 |
|
dc.relation.issn |
1935-5548 |
|